irinotecan,leucovorin,oxaliplatin,nab-paclitaxel,gemcitabine
Ipsen
[]
#ipsen presents phase iii #napoli3 trial of #onivyde regimen demonstrating positive survival results in previously untreated #metastatic #pancreaticductaladenocarcinoma at #ascogi23 $ipsey 
Follow top-line development in the oncology commercial domain through our award winning intelligence service, 1stOncology.